Vasculogenesis and hematopoiesis are essential for development. Recently, the ETS domain transcription factor Etv2 has been identified as an essential regulator of vasculogenesis and hematopoiesis. Here, we review the recent studies that have established the critical role of Etv2 in the specification of mesoderm to blood and endothelial cells.
INTRODUCTION
The vascular system is essential for embryogenesis and is one of the first organ systems to develop. Blood vessels initially form through the process of vasculogenesis, which first occurs in the extraembryonic yolk sac and subsequently in the embryo proper [1] . After primitive vessels have formed, the vascular plexus expands by endothelial sprouting and intussusceptive vessel growth in a process known as angiogenesis. Maturation of the vascular network also involves recruitment of mural cells for stabilization, and remodeling of blood vessels into arteries, veins and capillaries [2, 3] .
During vasculogenesis, the initial formation of endothelial progenitors (angioblasts) from the extra-embryonic mesoderm and hematopoietic cells also appear. These angioblasts and hematopoietic cells coalesce into blood islands, which fuse and form the primitive vascular plexus [4] . The close appearance of hematopoietic cells and endothelial progenitors in the extraembryonic mesoderm led to the hypothesis that they develop from a common progenitor, the hemangioblast. In embryonic stem cell differentiation experiments, researchers identified a mesodermal precursor called the blast colony-forming cell (BL-CFC), characterized by expression of Brachyury and Flk1, which gives rise to both endothelial and hematopoietic cells and represents the in vitro equivalent of the hemangioblast [5, 6] . Within the embryo, hemangioblasts have been shown to arise within the posterior primitive streak [7] , and recent studies established that hemangioblasts give rise to hematopoietic cells through a hemogenic endothelial intermediate [8, 9] .
Several major signaling pathways, including vascular endothelial growth factor (VEGF), bone morphogenetic protein (BMP), Notch, Wnt, and fibroblast growth factor (FGF) are required for induction of endothelial and hematopoietic lineages [7] , and much has been learned about the nonautonomous signals involved in vasculogenesis and angiogenesis. By comparison, much less is known about the transcription factors involved in vascular development. Recent studies have identified the ETS (E26 transformation specific) domain transcription factor Etv2 as an essential regulator of vasculogenesis and hematopoiesis. In this review, we highlight the role of Etv2 in the development of endothelial and blood lineages and discuss what has been learned about this transcription factor's function, lineage contributions, targets and cofactors.
THE ETS TRANSCRIPTION FACTOR Etv2 IS ESSENTIAL FOR ENDOTHELIAL AND HEMATOPOIETIC DEVELOPMENT
Members of the ETS family of transcription factors play important roles in endothelial development [1, 10] . There are approximately 30 members of the ETS family in vertebrates [11] . All ETS proteins share a highly conserved winged helix-turn-helix ETS DNA-binding domain and bind to a consensus GGAA/T-binding motif [11] . Many ETS proteins are expressed within hematopoietic and endothelial cells and are important in the development of these tissues. For example, erg is essential for definitive hematopoiesis in mice and is required for angiogenesis in zebrafish [12, 13] . The ETS transcription factor Etv6 controls angiogenic sprouting [14] , and Fli1 acts early in hemangioblast development by functioning upstream of many early endothelial and hematopoietic genes, including Flk1, Scl and Gata2 [15] . Loss of Fli1 function in Xenopus causes a severe decrease in the number of hemangioblasts [15] . However, in mouse and zebrafish, loss of Fli1 does not result in severe vascular defects [15] [16] [17] , suggesting that other ETS factors may compensate or that Fli1 is not absolutely required for hemangioblast specification. It is plausible that other ETS factors may function redundantly during embryogenesis to compensate for the loss of Fli1.
Recently, the essential role of Etv2 in endothelial and hematopoietic development has been clearly demonstrated in multiple vertebrate species. In contrast to other members of the ETS family, mouse knockouts for this gene die early in gestation and fail to develop any endothelial or hematopoietic cells [18, 19] . Fli1 has been proposed to act upstream of Etv2 [15] , but other studies show that Fli1 is downstream of Etv2 in mice and zebrafish [20 & ,21,22] . Additionally, Etv2 overexpression is sufficient to up-regulate fli1 expression in zebrafish [23, 24] (discussed below). Etv2-null mouse embryonic stem cells fail to differentiate into Flk1 þ vascular mesoderm from which endothelial and blood cells are derived [20 & ]. Mutation or knockdown of the zebrafish or Xenopus orthologs of Etv2 also causes severe vascular and endocardial defects [22, [25] [26] [27] [21] have shown that Etv2 is also required for the initiation of hematopoietic stem cell (HSC) development from hemogenic endothelium, demonstrating a requirement for Etv2 in definitive hematopoiesis in zebrafish.
In the mouse, definitive HSCs arise from hemogenic endothelium at E10.0 [32] [33] [34] . However, Etv2 À/À mouse embryos die prior to this stage [18, 19] , precluding an analysis of hemogenic endothelium formation in Etv2 germline-null mice. Recent work by Lee et al. [35 & ] demonstrated that when Etv2 function is removed exclusively from the hematopoietic system in adult mice, there was a significant decrease in HSCs. The authors of that study found that Etv2 was required for maintenance of HSCs, that HSC progenitors isolated from Etv2 À/À bone marrow exhibit reduced capacity to differentiate into granulocyte-monocyte progenitors, and that the number of myeloid lineage cells in the bone marrow was significantly reduced [35 & ]. These results are consistent with the role of Etv2 in zebrafish and Xenopus myeloid development. Thus, in addition to its requirement for endothelial cell specification, Etv2 is also required for HSC development, differentiation and maintenance ( Fig. 1 ), although further work needs to be done to clarify its role during mouse hematopoietic development.
Etv2 IS SUFFICIENT TO INDUCE ENDOTHELIAL AND HEMATOPOIETIC GENE EXPRESSION
In addition to the loss-of-function experiments described above, which demonstrate the requirement
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of Etv2 for endothelial and hematopoietic development, gain-of-function experiments performed in zebrafish and Xenopus embryos demonstrate that Etv2 is also sufficient to induce ectopic endothelial and myeloid marker expression [22-24,27,29 & ,31 ]. Overexpression of the ortholog of Etv2 in zebrafish embryos induces expression of endothelial markers flk1, scl and fli1 and the myeloid marker pu.1 [22] [23] [24] 31] . Likewise, injection of Etv2 mRNA into Xenopus embryos at an early stage into cells normally fated to be avascular endoderm results in ectopic induction of endothelial-specific markers flk1 and cd31 and the myeloid marker runx1 [27,29 & ]. This activity of Etv2 is profoundly enhanced by co-injection of mRNA encoding the Forkhead transcription factor FoxC2 ( [27] ; discussed below). Similarly, overexpression of Etv2 in embryonic stem cells strongly induces the formation of hematopoietic and endothelial progenitor cells, and Etv2 expression is sufficient to rescue formation of Flk1 þ mesoderm after inhibition of BMP, Notch, and Wnt signaling [19] .
EXPRESSION AND LINEAGE ANALYSES DEMONSTRATE AN EARLY ROLE FOR Etv2 IN ENDOTHELIAL AND HEMATOPOIETIC SPECIFICATION
Etv2 is essential for normal hematopoietic and endothelial development, but it is only expressed transiently in early progenitors in the mesoderm. In the mouse, Etv2 is expressed at the earliest site of endothelial cell development within the extraembryonic mesoderm in E7 mouse embryos [19,20 & ].
Etv2 expression persists in early progenitors and in newly formed endothelial cells, but expression rapidly fades and is essentially absent by E11.5 [18,19,20 & ,36 && ]. In zebrafish, the Etv2 ortholog etsrp is also expressed transiently within angioblasts and the early vasculature but is down-regulated as blood vessels mature [22, 37, 38 ]. The early expression of Etv2 in the mesoderm at sites where endothelial and hematopoietic progenitors arise, combined with the critical requirement for Etv2 during development, suggests that Etv2 is expressed and functions in the progenitors that give rise to the mature vasculature and to the hemogenic endothelium from which hematopoietic stem cells arise. Indeed, recent lineage tracing studies using an Etv2 enhancer to direct expression of Cre recombinase demonstrated that Etv2-expressing progenitors contribute to the vasculature of the developing embryo and to hematopoietic cells including CD45 þ nonerythroid and Ter119 þ erythroid cells [36 && ]. Similarly, Flk1 þ , Etv2 þ cells isolated from E7.5 or E8.5 embryos are enriched for cells that differentiate into hematopoietic lineages, including Mac1 þ , CD45 þ granulocytes and Ter119 þ erythroid cells [20 & ]. It is still unclear whether Etv2-expressing progenitors give rise to the entire vasculature or to what extent hematopoietic stem cells and hematopoietic lineages are derived from Etv2-expressing cells. A more detailed characterization of the lineages derived from Etv2 þ cells is still needed to gain a complete understanding of the origins of the vascular system.
Rasmussen et al.
[36 && ] also described a contribution of Etv2 þ cells to other mesodermal compartments, suggesting the possibility that Etv2 may play additional roles outside of the cardiovascular system. These extra-mesodermal contributions by Etv2-expressing cells need further investigation and confirmation using additional techniques, but raise the intriguing possibility of additional developmental roles for Etv2.
The differentiation of multipotent mesodermal progenitors requires tight control of cell fate, which recent studies demonstrate is achieved through reciprocal control of cardiac versus hematopoietic and endothelial fate (Fig. 1) . In zebrafish, the cardiac-restricted homeodomain protein Nkx2-5 [39, 40] acts downstream of FGF signaling to restrict hemangioblast fate, causing down-regulation of Etv2 and Scl, while promoting cardiac fate [41] . Similarly, in mice, Nkx2-5 acts to repress mesodermal differentiation to hematopoietic lineages and to promote cardiomyocyte development [42] , suggesting an antagonistic relationship between cardiomyocyte and endothelial/hematopoietic lineage commitment. In support of this notion, Etv2 has recently been shown to modulate these mesodermal cell fate decisions in favor of hematopoietic and endothelial differentiation at the expense of the cardiomyocyte lineage [ ]. These studies in mice are complemented by studies in zebrafish demonstrating that loss of Etv2 causes down-regulation of endocardial markers and expansion of myocardial gene expression [30 && ]. Furthermore, induction of Etv2 both in embryonic stem cells and zebrafish is sufficient to inhibit cardiac gene expression [19,36 && ]. Together, these observations emphasize the importance of Etv2 in the specification and differentiation of endothelial and hematopoietic cells from multipotent mesodermal progenitors, and suggest that it acts as a master regulator of mesoderm specification to the endothelial/hematopoietic lineage, possibly in an antagonistic relationship with the cardiac regulatory factor Nkx2-5 ( Fig. 1 ).
TRANSCRIPTIONAL TARGETS OF Etv2
To better understand how Etv2 controls development of hematopoietic and endothelial lineages, it is essential to identify the direct targets of Etv2 during early mesoderm development, and several studies have sought to identify Etv2 targets using genome-wide expression analyses. Microarrays have been carried out on zebrafish embryos and mouse embryonic stem cells overexpressing Etv2 and on Etv2::YFP, Flk1 þ , Pdgfra þ cells isolated from Etv2null mouse embryos [20 & ,23,24,36 && ]. A common conclusion that can be drawn from these studies is the important role that Etv2 plays in inducing the expression of essential endothelial and hematopoietic genes. Some of the direct targets of Etv2, which may mediate its downstream effects, include Flk1, Scl, Fli1, Gata2 and Tie2 [18,19,20 & ,27,35 & ]. Importantly, all of these targets are required for normal hematopoietic or vascular development [1, 43] . These microarray analyses also led to the identification of novel vascular and hematopoietic-restricted genes [23, 24] . Additionally, nfatc1, which encodes a REL domain transcription factor important in endocardial development, is also a transcriptional target of Etv2 in the endocardium of zebrafish [30 && ], suggesting that a distinct Etv2dependent transcriptional program may function in the endocardium compared to the vascular endothelium.
Another interesting outcome of recent genomewide transcriptional analyses performed in Etv2-null cells and embryos is the observation that expression of genes associated with other mesodermal lineages, including the cardiac lineage, is increased in the absence of Etv2, further supporting the notion that Etv2 function promotes mesodermal specification to the endothelial/hematopoietic lineage and represses cardiomyocyte specification [30 && ,36 && ]. This raises an interesting question as to whether cardiac genes are repressed directly or indirectly by Etv2. Further work needs to be carried out to determine whether Etv2 may act as a transcriptional repressor, potentially through interactions with cofactors.
As an alternative approach for identification of Etv2 targets, our lab identified a novel FOX:ETS motif [27] , which is strongly associated with endothelial genes and provides predictive power for endothelial enhancers (Fig. 2) . The FOX:ETS motif is bound by Etv2 in combination with Forkhead transcription factors, including FoxC2 [27] . Etv2 and FoxC2 bind to the FOX:ETS motif and cooperatively activate endothelial enhancers containing that motif (Fig. 2, [27] ).
Regardless of the experimental or bioinformatic methodology used, the identification of Etv2 targets represents an important starting point for understanding the genetic networks and mechanisms governing endothelial and hematopoietic development. 
REGULATION OF Etv2: SIGNALING PATHWAYS AND TRANSCRIPTIONAL REGULATION
As described in this review, Etv2 plays an essential role in endothelial and hematopoietic development and numerous studies have suggested that it acts at or near the top of the hierarchy in the specification of those lineages [19, 20 & ,30 && ,36 && ]. Furthermore, Etv2 exhibits very dynamic and transient expression during endothelial development ( [18, 19, 20 & ,36 && ]; K.L. and B.L.B., unpublished observations). Thus, it is important to understand how Etv2 is activated in the early mesoderm. The rapid extinction of Etv2 expression and function also suggests a highly regulated transcriptional shut off as well. Transcriptional regulators, post-translational modifications, and epigenetic mechanisms appear likely to play major roles in Etv2 regulation.
To understand how Etv2 is transcriptionally regulated during development, several groups have identified conserved Etv2 promoter and enhancer elements that are active at sites of endogenous Etv2 expression, leading to the identification of transacting factors that bind to and regulate Etv2 expression. Recently, Veldman and Lin [38 & ] identified a conserved cis-acting element in zebrafish Etv2 (etsrp) that directs expression to angioblasts and the developing vasculature. They showed that FoxC1a and FoxC1b bind to this enhancer region and are required for Etv2 expression in endothelial progenitors [38 & ]. Although Etv2 expression is reduced, some expression is retained, suggesting that other factors are required for the initial induction of Etv2. Furthermore, mouse Foxc1 and Foxc2 mutants do not exhibit as severe defects as Etv2 mutants [44] , suggesting that critical upstream regulators are still unknown. A 3.9-kb promoter/enhancer element from the mouse Etv2 locus has also been identified. This element directs expression to the developing vasculature and endocardium [18] . Nkx2-5, which is a critical regulator of myocardial and endocardial development [39, 40] , acts upstream of Etv2 via the 3.9-kb promoter/enhancer in the endocardium [18] . However, it is unclear whether Nkx2-5 regulates the expression of Etv2 within endothelial progenitors in the early mesoderm. Notably, the expression of Etv2 precedes expression of Nkx2-5 in the early mesoderm ([36 && ]; K.L. and B.L.B., unpublished observations), suggesting that factors other than Nkx2-5 are likely to be responsible for the initial activation of Etv2 in mesodermal progenitors. Furthermore, loss of Nkx2-5 in mice or overexpression in embryonic stem cells does not affect endothelial differentiation [42] . On the other hand, ectopic overexpression of Nkx2-5 causes down-regulation of Etv2 and other hemangioblast markers in zebrafish and affects hematopoietic development in embryonic stem cells [41, 42] .
In addition to transcriptional regulators, some of the signaling pathways that induce Etv2 expression have been identified. BMP, Notch and Wnt signaling are required for induction of Etv2 expression in BL-CFCs and the subsequent formation of Flk1 þ mesoderm and endothelial and hematopoietic cell differentiation [19] . Importantly, other studies have demonstrated that Etv2 is not essential for the generation of all Flk1 þ mesoderm. Rather, Etv2 is essential for the generation of Flk1 þ , Pdgfra À vascular mesoderm from primitive Flk1 þ , Pdgfra þ mesoderm, and VEGF signaling was shown to be a robust inducer of Etv2 expression within primitive mesoderm [20 & ]. The SHH-VEGF-Notch signaling axis has also been reported to be important in the proliferation of Fli1 þ , Etv2(etsrp) þ hematopoietic/ endothelial progenitors in zebrafish [37] . However, it is unclear whether this pathway is required for specification or only for proliferation of these progenitors.
Regulation of Etv2 function by cofactors
Transcription factors often interact with other proteins to increase target specificity or modulate function. As previously mentioned, Etv2 interacts with members of the Forkhead family, including FoxC2, to synergistically activate endothelialspecific gene expression [27] . Etv2 and FoxC2 act combinatorially to induce ectopic endothelial gene expression in Xenopus embryos, but the mechanism by which these two factors promote synergistic activation is still unknown. It is possible that Etv2-FoxC2 interaction facilitates recruitment of additional proteins that provide strong activation or induce post-translational modifications. Interestingly, Etv2 also interacts with the histone demethylase Jmjd1a to repress transcriptional activation of the Etv2 target gene, Mmp1 [45] . Interestingly, Jmjd1a alters the self-renewal of embryonic stem cells through demethylation and positive regulation of pluripotency-associated genes [46] . Thus, Jmjd1a represents a good candidate for the modification of Etv2 function during vasculogenesis, possibly by affecting the balance between progenitor maintenance and differentiation, but its effect on Etv2 targets during endothelial and hematopoietic development are unknown.
Chromatin modifications play an integral role in the regulation of embryonic stem cell differentiation to multiple lineages. Further studies should determine how histones at the Etv2 locus are modified during its induction and repression. Other ETS transcription factors are subject to post-translational modifications, which alter their function. Phosphorylation, acetylation, sumoylation, and ubiquitination have all been shown to affect the transcriptional activity of numerous ETS factors [10] . A detailed characterization of the post-translational modifications of Etv2 and how those modifications affect transcriptional activity is needed to properly understand how Etv2 functions in endothelial specification.
CONCLUSION
Although much remains to be learned about the regulation and function of Etv2 in endothelial and hematopoietic development, studies over the past few years have clearly established its role as an essential regulator of specification of these lineages from the early mesoderm. Future studies will define the upstream transcriptional activators of Etv2 in the early mesoderm and will identify cofactors that modulate Etv2 activity, and it will be interesting to determine if Etv2 has roles in other mesodermal lineages or if it is reutilized in response to physiological or pathological stimuli in the postnatal vasculature.
